Colokit

Quick links to important sections

Colokit

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Colokit

Quick Facts

Property Description
Active Ingredient Monosodium Phosphate, Disodium Phosphate
Form Oral Tablets
Pharmacological Class Osmotically Acting Laxative (Saline)
General Purpose Bowel Preparation/Colon Cleansing
Origin Synthetic Mineral Salts

What is Colokit and Its Pharmaceutical Classification?

Colokit is a prescription-only medicinal product supplied as an oral preparation in tablet form. This medication is classified pharmacologically as a laxative, specifically falling under the category of osmotically acting laxatives, which utilize mineral salts for their function. Its high-level classification as a saline laxative defines its powerful mechanism, differentiating it from stimulant or bulk-forming laxatives by relying on the physical principle of osmosis. The formulation's primary distinction is its delivery in a tablet form, recognized as an alternative to the liquid sodium phosphate solutions historically used for similar preparatory needs.


Active Ingredients: Composition and Origin

The product is defined as a combination product because its active components are two distinct, synthetic mineral salts: Monosodium Phosphate monohydrate and Anhydrous Disodium Phosphate. These salts are chemically manufactured and serve as the essential osmotic agents. The efficacy of sodium phosphate preparations for this specific purpose is recognized and supported by pharmacological studies focused on achieving clear visualization during diagnostic procedures. This formulation is positioned for adults requiring comprehensive colon evacuation and is distinct from newer Polyethylene Glycol (PEG)-based preps.


What is the General Purpose of Colokit?

The general purpose of Colokit is to achieve thorough colon cleansing or bowel preparation. The function is driven by the strong osmotic action of the phosphate salts, which draw substantial volumes of water from the body’s tissues directly into the intestine. This physiological effect, characteristic of a saline laxative, results in the rapid and comprehensive evacuation of the bowel. This action ensures the colon is empty and clean for specific diagnostic examinations, such as colonoscopy preparation, which is the medicine's typical, neutral use scenario.

Regulatory References

  1. MedlinePlus: Colonoscopy Bowel Prep

What side effects are possible with Colokit?

Classification of Adverse Reactions

Adverse reactions associated with sodium phosphate preparations are classified by frequency and the affected body system, according to official regulatory documents. Side effects are primarily related to the strong osmotic action required for thorough bowel cleansing.

Common Adverse Reactions

Reactions classified as common (affecting up to 1 in 10 people) involve the Gastrointestinal System and general systemic effects. These include abdominal pain or discomfort, nausea, vomiting, and the expected occurrence of diarrhea. Systemic effects commonly listed are headache and dizziness.

Less Common Adverse Reactions

Less frequently observed effects, including uncommon and rare classifications, primarily involve the body’s chemistry. These effects include dehydration and various electrolyte disturbances, such as changes in potassium, sodium, or calcium levels. Allergic reactions, such as rash or itching, are also documented safety concerns.


Documented Serious Safety Concerns

Official labeling describes specific reactions that are considered serious, emphasizing risks to organ systems. Acute phosphate nephropathy, a form of acute kidney injury caused by calcium-phosphate deposits in the kidneys, is a serious adverse reaction documented for oral sodium phosphate products. This condition can potentially lead to permanent renal impairment. Severe fluid and electrolyte abnormalities are also considered critical safety concerns, as they can lead to complications such as cardiac arrhythmias or seizures.


Population-Specific Safety Notes

The risk of serious adverse reactions, particularly acute phosphate nephropathy and electrolyte changes, is documented as increased in older adults. The preparation is contraindicated in individuals with severely impaired renal function due to a significantly elevated risk of toxicity. Patients with pre-existing conditions like congestive heart failure also require specific safety consideration.

Overdose and Emergency Response

Overdose and When to Seek Help

An overdose of oral sodium phosphate preparations is formally documented by regulatory authorities to cause severe, potentially life-threatening systemic toxicity primarily driven by profound metabolic disruption. Overdosage may lead to critical electrolyte abnormalities, specifically severe hyperphosphatemia and hypernatremia, which subsequently cause hypocalcemia.

Documented clinical manifestations of overdose include neurological effects, such as seizures and drowsiness, and cardiovascular effects like irregular heartbeat and cardiac arrhythmias. Life-threatening outcomes cited in regulatory labeling involve serious harm to the heart and the renal system, including acute phosphate nephropathy, which can result in permanent impairment of kidney function or the requirement for long-term dialysis.

Immediate medical attention is required when specific signs appear. Regulatory guidance mandates seeking emergency medical care if an individual experiences symptoms of severe volume depletion, significant vomiting, trouble breathing, inability to wake up, or signs of acute kidney injury, such as decreased urination or swelling of the extremities. Patients over 55, those with pre-existing kidney disease, heart failure, or severe dehydration are officially documented to be at increased risk of severe outcomes. Management, as defined by official labeling, is supportive, focusing on the immediate discontinuation of the product and urgent correction of the severe electrolyte imbalances.

Therapeutic Uses of Colokit

What Colokit Treats: Main Uses and Benefits

Colokit's primary use plays a role in managing the necessary level of bowel cleansing required for specialized gastrointestinal examinations. It is indicated for cleansing of the bowel as a preparation for colonoscopy in adults. The preparation is also relevant in contexts involving heightened systemic burden, such as before lower radiological imaging and specific colorectal surgeries.

The core benefit is applied in addressing the goal of achieving full colonic clearance, contributing to the visualization quality required for thorough inspection, which may assist with managing symptoms related to organ-specific functional stress. The goal of using the preparation is to support the patient during difficult episodes by easing distress related to the cleansing process. It is commonly used to help with achieving adequate preparation, which may assist in maintaining procedural schedules and avoiding the need for a repeated preparation. This provides support that helps ease the overall symptom burden associated with the intensive cleansing requirement.

Quick Fact Use Context
Relief for Obstruction Used when retained stool and contents must be completely cleared.
Main Indication Bowel cleansing before diagnostic procedures and surgery.
Benefit Supports the achievement of visualization quality required for inspection.

Eligibility and Restrictions for Use

Who can and cannot use Colokit?

Colokit (Sodium Phosphate Tablets) is officially approved for use only in adults aged 18 years and older. Use in the pediatric population is not established by regulatory bodies, meaning safety and efficacy data are insufficient for this age group.

The medicine is strictly contraindicated and must not be used in patients with biopsy-proven acute phosphate nephropathy or known hypersensitivity to any of its components.

Eligibility is severely restricted or prohibited in populations with specific pre-existing conditions. Absolute non-eligibility is defined by critical gastrointestinal pathologies such as bowel perforation, GI obstruction, toxic megacolon, gastric retention, and severe inflammatory conditions. Conditional use applies to patients with severe renal impairment or other baseline kidney disease, as well as those with congestive heart failure or unstable angina.

Older adults and patients taking concurrent medications like diuretics or ACE inhibitors are considered restricted-use populations requiring caution. For pregnancy and lactation, the medicine is classified for conditional use only, as safety has not been formally studied and it should be used only if clearly needed.

What should I know about interactions with other medicines?

Colokit, an oral sodium phosphate preparation, has documented interaction patterns that primarily relate to changes in absorption of other drugs and pharmacodynamic risks associated with fluid and electrolyte balance.

Contraindicated Combinations

Co-administration with other sodium phosphate-based laxatives (purgative or enema products) is strictly contraindicated due to the high risk of additive phosphate exposure, which may lead to severe electrolyte disturbances and potential renal injury.

Pharmacodynamic Risk Enhancement

Concurrent use with several classes of prescription medicines increases the official risk of renal impairment and serious electrolyte abnormalities.

Interacting Product Category Interaction Mechanism (Official Description)
Diuretics, ACE Inhibitors, ARBs, NSAIDs Increases the risk of fluid and electrolyte disturbances and acute phosphate nephropathy (a form of renal injury).

Absorption and Timing Rules

Because the preparation causes rapid evacuation of the bowel, co-administration with other oral medicines can result in reduced absorption and lower systemic exposure of the co-administered drug. The label mandates that all other oral medications must be separated from Colokit doses by at least 1 hour.

Food, Substance, and Population Constraints

During the preparation period, consumption of alcohol, solid food, and dairy products is restricted. The risk of serious, interaction-related adverse events is officially heightened in elderly patients and those with baseline kidney disease when co-administered with the listed pharmacodynamic interacting agents.

Mechanism of Action

Reversal of Fluid Transport via Osmotic Action

The primary mechanism relies on the phosphate salts acting as non-absorbable solutes within the intestinal lumen. This establishes a powerful osmotic gradient across the colonic epithelium, a key mechanistic domain that reverses the normal flow of water. This action forces a substantial net shift of fluid from the body's tissues into the large intestine.


Motility Activation via Mechanical Distention

The substantial volume of fluid sequestered in the colon creates significant mechanical distention of the intestinal walls, which is the second core mechanistic domain. This stretching acts as a powerful physical stimulus, triggering autonomic nerve plexuses to initiate propulsive peristaltic contractions. This cascade translates the initial fluid accumulation into a rapid, propulsive, and thorough physiological evacuation.


Functional Synergy and Systemic Constraint

The formulation uses a combination of two distinct phosphate salts to maximize the osmotic load while maintaining a necessary buffering capacity to support sustained osmotic function. This strong osmotic mechanism inherently modulates systemic fluid and electrolyte homeostasis, a functional constraint where the potency of the action directly influences the body's mineral balance, thereby defining the physiological boundaries of the osmotic mechanism.

Dosage and Administration Information

How to use Colokit — Official Administration Guidelines

The usage of Colokit, which contains Monosodium Phosphate and Disodium Phosphate, is governed by a precise, non-routine protocol. The full regimen requires a fixed quantity of tablets administered in two distinct phases.

Administration Scope Detail
Route of administration The product is for oral administration only, in tablet form, for use in adults.
Dosing schedule The complete preparation requires a total of 32 tablets, divided into a two-phase schedule: 20 tablets (First Dose) and 12 tablets (Second Dose).
Timing in relation to meals (if applicable) Patients must switch to clear liquids only after midday on the day before the procedure, and no oral medications are to be taken within one hour of starting each dose.
Preparation requirements (if applicable) Each four-tablet sub-dose must be swallowed with 8 ounces (250 mL) of clear liquid. Patients are directed to consume a total of 2 quarts of clear liquids with the tablets.
Age-group administration rules The preparation is for use in adults only; it is not authorized for patients under 18 years of age.
Special procedural conditions The preparation must not be administered within 7 days of a previous use, and concurrent use of other sodium phosphate laxatives is prohibited.

Instruction Classifications (High-Level)

Classification Detail
Administration method type Oral
Frequency pattern As-needed (for a single scheduled procedure).
Basis Prescribing information.

Resulting Procedural Structure

Official step sequence:

  • Evening Before: Begin the First Dose (20 tablets) by taking 4 tablets with 8 oz of clear liquid. Repeat this cycle every 15 minutes until all 20 tablets are consumed.
  • Procedure Day Morning: Begin the Second Dose (12 tablets) 3 to 5 hours before the scheduled examination. Take 4 tablets with 8 oz of clear liquid, and repeat every 15 minutes until all 12 tablets are consumed.
  • Hydration: Continue to ingest clear liquids throughout the entire preparation period.

Connection to the overall use protocol: The official instructions establish a precise split-dose regimen taken orally, designed to standardize the administration of the phosphate salts across two phases. This protocol’s structure is dependent on adherence to the 15-minute interval timing and the mandatory co-administration of clear liquid for each sub-dose. This specific, short-term usage pattern is intended for use in adult patients prior to a scheduled examination.

Recent Clinical Evidence

Research evidence / Overview of studies for Colokit

Research Evidence for Bowel Cleansing Before Colonoscopy

Colokit tablets have been the focus of studies examining bowel cleansing as a preparation before a colonoscopy. Studies exploring this area are mainly short-term randomized controlled trials (RCTs), applied in research examining patient-reported experiences and procedural outcomes. Researchers examined bowel cleansing quality and patient experience metrics, often comparing the tablet formulation against large-volume liquid preparations like those based on Polyethylene Glycol (PEG).

The main outcomes monitored included bowel cleansing quality and the rates of preparation completion. Research describes patterns observed in the studies, where the quality of the preparation was monitored for adequacy of visualization. Research provides insight into how patients reported their perceived discomfort and preparation completion rates.

Research Evidence for Other Diagnostic Procedures

The research base for the tablet formulation in other diagnostic procedures, such as preparation for lower radiological imaging or colorectal surgery, is not as comprehensive as the evidence for colonoscopy preparation. Studies focusing on episodes where symptoms become more noticeable in this context often rely on extrapolation from the more robust colonoscopy data. Research has explored the cleansing quality measured for these specific procedures.

Research in Specific Populations and Evidence Gaps

Clinical research for Colokit was primarily evaluated in populations composed mainly of adults who were generally healthy. Data for certain groups remain insufficient, especially for patients who are older adults or those with significant chronic comorbidities, such as severe heart or kidney conditions. These groups were often intentionally excluded from the core short-term RCTs, meaning the study results reflect the specific conditions under which they were conducted. The short-term focus means that long-term effects are not fully established, as follow-up durations were typically limited to the day of the procedure.

Frequently Asked Questions (FAQ)

Common questions about Colokit (FAQ)


Q: Does Colokit affect my blood pressure?

Official product information advises caution for patients with existing hypertension and those taking certain blood pressure medications (like ACE Inhibitors or ARBs).

This is because the use of Colokit increases the risk of fluid and electrolyte imbalances. These types of imbalances could potentially impact patients with underlying cardiovascular conditions.


Q: Can I take Colokit with my daily vitamins or supplements?

Regulatory documents indicate that the rapid bowel cleansing process may reduce the absorption of any product taken orally, including vitamins and supplements.

Regulatory guidance describes a minimum separation of at least one hour between Colokit doses and any other oral product.


Q: Can Colokit be taken with antacids or heartburn medicine?

Like other oral medicines, antacids or heartburn medications may have reduced effectiveness because the rapid emptying of the bowel reduces their absorption time.

The official product information establishes a requirement that all oral medicines be separated from Colokit doses by at least one hour.


Q: Do regulatory agencies classify Colokit as a high-risk drug?

Official regulatory bodies have placed specific warnings on prescription oral sodium phosphate products due to the risk of serious side effects.

These warnings describe the importance of careful patient selection and clinical monitoring during use, highlighting risks like potential kidney injury (acute phosphate nephropathy) and severe electrolyte disorders.


Q: Does Colokit interact with birth control pills?

Official information states that because Colokit causes rapid bowel evacuation, the absorption of all oral medications, including oral birth control pills, may be reduced.

For this reason, the product label specifies that a separation of all oral medications from Colokit doses by at least one hour is necessary.


Q: Is it safe to drive or operate machinery while taking Colokit?

Regulatory documents list common side effects such as dizziness and headache associated with using Colokit.

Due to these potential effects, official guidance references exercising caution with activities that require full mental alertness and physical coordination.


Q: How quickly does Colokit usually start to work?

Studies and official product information report that the cathartic, or bowel-cleansing, action usually begins approximately 3 to 6 hours after a patient takes the first dose of the regimen.


Q: Is it safe to drink coffee while taking Colokit?

According to official regulatory documents, black coffee is generally permitted as a clear liquid that can be consumed as part of the preparation regimen.

However, the regulatory text specifies that coffee is permitted only when consumed without any milk, cream, or non-clear additives, which are restricted.


Q: What does 'contraindicated' mean in the context of Colokit?

The term contraindicated means that the medication is officially prohibited from use if a patient has a specific medical condition listed in the official documents.

This describes a circumstance under which the medicine's use would carry a significantly elevated risk of harm, such as severe kidney impairment or certain serious gastrointestinal issues.


Q: What ingredients are in the Colokit pill, besides the active part?

In addition to the active ingredients (Monosodium Phosphate and Disodium Phosphate), the tablets contain inactive ingredients, or excipients, used to form the pill.

These typically include substances such as polyethylene glycol 8000 and magnesium stearate.


Q: How can I tell if Colokit is working for me?

The function of the medication is to thoroughly cleanse the colon, which is achieved by causing a rapid, forceful diarrhea.

The preparation is considered successful when the resulting evacuation is liquid, clear, and free of any solid fecal matter.


Q: What should be checked before starting treatment with Colokit?

For patients considered at high risk of complication, regulatory documents reference obtaining baseline blood work prior to starting treatment.

This testing is done to monitor the body's mineral levels (electrolytes like calcium, phosphate, and potassium) and to assess existing kidney function.


Q: Can people with diabetes use Colokit?

While diabetes is not listed as an absolute contraindication, official information and studies indicate that patients with this condition are considered part of a high-risk subgroup.

For this reason, regulatory information describes the use of caution and close clinical monitoring.


Q: Does Colokit have a 'Black Box Warning' in the US?

The FDA issued a public Warning on prescription sodium phosphate tablets regarding the risk of acute kidney injury (acute phosphate nephropathy).

While this may be referred to in clinical conversation as a key safety alert, official documents describe it as a significant risk that requires special attention and communication to prescribers.


Q: What is the relationship between Colokit and similar drug names I see online?

Colokit is a brand name for the oral sodium phosphate tablet formulation used for bowel cleansing.

Other similar names online may refer to different brand names of the same product (like OsmoPrep) or to alternative types of laxative preparations, such as liquid versions of sodium phosphate.


Q: How long does Colokit stay in the body after the last use?

Official product labeling for breastfeeding patients provides guidance that milk should be discarded for 24 hours after the final dose of the regimen.

This 24-hour time frame is the guidance provided regarding the clearance of the medication from the system.


Q: How is the safety of Colokit tracked after it is approved?

The safety of Colokit after its approval is tracked through pharmacovigilance programs like the FDA's MedWatch Adverse Event Reporting program.

This allows both patients and healthcare providers to voluntarily report any adverse reactions or quality problems that occur during general use.


Q: Does Colokit contain lactose or gluten?

Official product information for the equivalent tablet formulation indicates that the product is explicitly labelled as gluten-free.

The listed inactive ingredients in the tablet preparation do not contain lactose.

How should Colokit be stored and disposed of?

How to Store and Dispose of Colokit

Official labeling defines specific requirements for storing Colokit tablets to ensure stability and safety.

Storage Requirement Official Instruction
Temperature Store at room temperature and away from excess heat and moisture [2.4].
Container Keep the container tightly closed and store in its original packaging [2.4].
Child Safety Must be kept out of the sight and reach of children [2.4].

Disposal must adhere to regulatory guidelines for unused or expired product. The official recommendation is to return the medicine to a drug take-back program [2.8]. If a take-back option is unavailable, the tablets should be removed from their container, mixed with an unappealing substance, and placed in a sealed bag before discarding in household trash [2.8]. The product must not be flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Colokit found in:

A-Z Index: